Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells
March 18th, 2019
Here we present a protocol for human Dental Pulp Stem Cells isolation and propagation in order to evaluate the prion protein expression during neuronal differentiation process.
Overview
This article presents a protocol for the efficient isolation and propagation of human Dental Pulp Stem Cells (DPSCs). The study evaluates prion protein expression during the neuronal differentiation process, highlighting the potential applications in regenerative medicine.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Biology
- Regenerative Medicine
Background
- Dental pulp is a rich source of stem cells.
- Current isolation methods are inefficient and variable.
- Understanding prion protein expression is crucial for neuronal differentiation.
- Efficient DPSC isolation can aid in creating biobanks for research.
Purpose of Study
- To develop a reliable protocol for DPSC isolation.
- To evaluate prion protein expression during neuronal differentiation.
- To provide a resource for regenerative medicine applications.
Methods Used
- Isolation of stem cells from treated teeth.
- Evaluation of cell viability and proliferation.
- Assessment of prion protein expression.
- Collaboration with experienced dental professionals.
Main Results
- Achieved a 90% success rate in DPSC isolation.
- High cell yield in a short time frame.
- Demonstrated prion protein expression during differentiation.
- Established a foundation for future regenerative medicine research.
Conclusions
- The developed protocol significantly improves DPSC isolation efficiency.
- Understanding prion protein expression can enhance neuronal differentiation studies.
- This work supports the creation of a biobank for scientific research.
Frequently Asked Questions
Executive Industry Relevance
Human Dental Pulp Stem Cells (hDPSCs) offer a bioethically accessible source of mesenchymal stem cells for regenerative medicine and neurodegenerative disease research. The protocol enables efficient isolation and propagation, supporting scalable production of disease-relevant cellular models. Demonstrated prion protein (PrPC) upregulation during neuronal differentiation positions hDPSCs as a mechanistic tool for target validation in neurotherapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of PrPC role in neuronal differentiation, supporting target hypothesis testing for neurodegenerative indications.
- Operational Value: Provides a reproducible human-derived stem cell model for early-stage target de-risking.
Screening & Assay Development
- Scientific Value: Generates standardized neuronal-like cells expressing beta-three-tubulin, NFH, and GAP43 for compound screening assays.
- Operational Value: Supports high-yield cell production (90% isolation success) enabling assay scalability and reproducibility.
Translational & Preclinical Research
- Scientific Value: Models human MSC-to-neuron transition, facilitating biomarker alignment and pathophysiological mechanism study.
- Operational Value: Enables longitudinal tracking of PrPC expression as a translational readout for differentiation efficacy.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing a renewable source of neuronal-like cells for target engagement and pathway analysis prior to lead optimization.
- Discovery Biology: Supports hypothesis testing on PrPC function in neuronal commitment and neurite outgrowth.
- Screening: Delivers standardized, adherent hDPSC-derived neurons for compound-induced phenotypic screening.
- Analytics: Enables quantitative flow cytometry and Western blot readouts for PrPC and neuronal marker expression.
- Translational Research: Connects in vitro differentiation to neurodegenerative disease models via PrPC modulation.
- Enterprise Reuse: Establishes a scalable biobank-compatible stem cell source for multi-project reuse across neuroscience programs.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of PrPC as a regulator of neuronal differentiation in human MSCs.
- Operational Value: Standardized isolation protocol reduces variability and increases throughput for stem cell production.
- Strategic Value: Informs go/no-go decisions on PrPC-targeted therapeutics by linking target modulation to phenotypic outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization of neuroprotective candidates based on differentiation competence in a human-relevant system.
Implementation Considerations
- Requires expertise in stem cell culture, neuronal differentiation, and flow cytometry.
- Dependent on access to human third molars and sterile tissue processing under biohazard conditions.
- Necessitates standardized reagents including collagenase IV, trypsin-EDTA, and neuronal induction media (EGF/bFGF).
- Adaptation to other MSC sources may require optimization of enzymatic dissociation and differentiation conditions.
- PrPC knockdown efficacy depends on siRNA delivery efficiency and incubation timing relative to induction stimuli.
Biopharma FAQs
Chapters in this video
0:04
Title
0:47
Tooth and Dental Pulp Extraction
1:29
Processing of the Dental Pulp and Stem Cell Release
2:29
Stem Cell Culture and Propagation
3:44
Transient PrPC Silencing by siRNA
5:04
Neuronal Induction Process of hDPSCs
5:50
Characterization of hDPSCs by Flow Cytometry
8:03
Evaluation of PrPC Expression in hDPSCs by Flow Cytometry Analysis
9:14
Results: hDPSCs Isolation and Propagation and the Role of PrP During Neuronal Differentiation
10:54
Conclusion
